BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strik AS, D'Haens GR, Löwenberg M. Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report. Clin Case Rep 2019;7:2049-53. [PMID: 31788249 DOI: 10.1002/ccr3.2394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Toplicanin A, Toncev L, Matovic Zaric V, Sokic Milutinovic A. Autoimmune Hemolytic Anemia in Inflammatory Bowel Disease—Report of a Case and Review of the Literature. Life 2022;12:1784. [DOI: 10.3390/life12111784] [Reference Citation Analysis]
2 Than NTT, Yaşar Ç, Pham BH, Lam BC, Doan HL, Akhavanrezayat A, Halim MS, Iberri DJ, Hien DL, Dong Nguyen Q. Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab. American Journal of Ophthalmology Case Reports 2022. [DOI: 10.1016/j.ajoc.2022.101752] [Reference Citation Analysis]
3 Berger M, Abdalla M, Decross A. Hemolytic Anemia in Inflammatory Bowel Disease: Our “Gut” Tells Us to Blame the Drug. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab070] [Reference Citation Analysis]
4 D'Haens GR, van Deventer S. 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future. Gut 2021;70:1396-405. [PMID: 33431575 DOI: 10.1136/gutjnl-2019-320022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
5 Hanzel J, Jansen JM, Ter Steege RWF, Gecse KB, D'Haens GR. Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study. Inflamm Bowel Dis 2022;28:495-501. [PMID: 34013959 DOI: 10.1093/ibd/izab099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Infliximab/mercaptopurine. Reactions Weekly 2020;1785:285-285. [DOI: 10.1007/s40278-020-73266-6] [Reference Citation Analysis]